Top shareholders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q3 2014
As of 30 Sep 2014,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
50 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,894,149 shares.
The largest 10 holders included
Third Rock Ventures, LLC, FMR LLC, ORBIMED ADVISORS LLC, DEERFIELD MANAGEMENT CO, RS INVESTMENT MANAGEMENT CO LLC, ALLIANCEBERNSTEIN L.P., PERCEPTIVE ADVISORS LLC, FEDERATED INVESTORS INC /PA/, FRANKLIN RESOURCES INC, and BlackRock Fund Advisors.
This page lists
50
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
Investor
Option
Weight %
Change %
Value $
* Price
Shares
Share Change
Activity
Report Period
Compare Q3 2014 vs Q4 2025 Across Filers
Q4 2025 holders
2
Q3 2014 holders
50
Holder diff
48
Investor
Q4 2025 Shares
Q3 2014 Shares
Share Diff
Share Chg %
Q4 2025 Value $
Q3 2014 Value $
Value Diff $
Value Chg %
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and, if you allow them, measure engagement and deliver
advertising. Analytics and marketing storage stay off until you grant
consent. By clicking on "Agree and continue", you declare your consent to
the use of the selected optional cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.